By Dietrich Knauth
March 14, 2025

March 14 (Reuters) – A Missouri judge has ordered Abbott Laboratories (ABT.N), and Reckitt Benckiser (RKT.L), unit Mead Johnson to face a new trial over allegations that they failed to warn a mother about the risks of their specialized baby formulas for premature infants, re-opening a case that had resulted in a victory for the defendants.

The Thursday ruling comes months after a St. Louis, Missouri state court found that the companies were not responsible for a young boy’s debilitating intestinal disease. The case had been a victory for the two companies following large losses in similar trials that had rattled investors.

Read full article here.